Abstract

Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5‐year analysis of the French early access program (EPA)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma: Real World Evidence from the French Early Access Program
Guillaume Manson ...
Blood | VOL. 132
Guillaume Manson, et. al.Guillaume Manson ...
29 Nov 2018
Impact of Achieving an Early Complete Response in Multiple Myeloma and Predictors of Subsequent Outcome
Marcella Kaddoura ...
Blood | VOL. 138
Marcella Kaddoura, et. al.Marcella Kaddoura ...
05 Nov 2021
Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience
Derya Koyun ... Mutlu Arat
Blood | VOL. 142
Derya Koyun, et. al.Derya Koyun ... Mutlu Arat
02 Nov 2023
Outcomes of DLBCL Patients Achieving Complete Remission after R-ICE Chemoimmunotherapy
Paolo F Caimi ... Brian T Hill
Blood | VOL. 140
Paolo F Caimi, et. al.Paolo F Caimi ... Brian T Hill
15 Nov 2022
View more papers

More From: British journal of haematology

Paper Title
Journal
Date
Author
Shift in emergency department utilization by frequent attendees with sickle cell disease during the COVID-19 pandemic: Amulticentre cohort study.
J S Rech ... O Steichen
British journal of haematology | VOL. -
J S Rech, et. al.J S Rech ... O Steichen
03 Jul 2024
Azacitidine combined with interferon-α for pre-emptive treatment of AML/MDS after allogeneic peripheral blood stem cell transplantation: A prospective phase II study.
Chongmei Huang ... Xianmin Song
British journal of haematology | VOL. -
Chongmei Huang, et. al.Chongmei Huang ... Xianmin Song
03 Jul 2024
Development of novel humanized CD19/BAFFR bicistronic chimeric antigen receptor T cells with potent antitumor activity against B-cell lineage neoplasms.
Sungui Wu ... Bing Chen
British journal of haematology | VOL. -
Sungui Wu, et. al.Sungui Wu ... Bing Chen
03 Jul 2024
A novel scoring model for predicting efficacy and guiding individualised treatment in immune thrombocytopaenia.
Min Xu ... Heng Mei
British journal of haematology | VOL. -
Min Xu, et. al.Min Xu ... Heng Mei
03 Jul 2024
View more papers